Management of constipation in children and adolescents with autism spectrum disorders

Glenn T Furuta1, Kent Williams, Koorosh Kooros

  • 1Digestive Health Institute, Section of Pediatric Gastroenterology, Hepatology and Nutrition, Children's Hospital Colorado, University of Colorado Denver School of Medicine, Aurora, Colorado, USA.

Pediatrics
|November 3, 2012
PubMed

Insights

Primary health care providers can use a new algorithm to identify, evaluate, and manage constipation in children with autism spectrum disorder (ASD). This systematic approach addresses constipation and its causes in children with ASD.

Area of Science:

  • Pediatric Gastroenterology
  • Autism Spectrum Disorders (ASDs) Research

Background:

  • Constipation is a common issue in children with autism spectrum disorder (ASD).
  • Identifying and managing constipation in this population presents unique challenges due to potential atypical symptom presentation.

Purpose of the Study:

  • To develop a practical, evidence-based algorithm for primary health care providers.
  • To guide the identification, evaluation, and management of constipation in children with ASDs.

Main Methods:

  • Expert opinion and literature review by the Autism Speaks Autism Treatment Network (ATN) Gastroenterology Committee.
  • Algorithm development guided by consensus and field testing by ATN autism medical specialists.
  • Systematic review and grading of existing literature on constipation in children with ASDs.

Main Results:

  • Consensus identified that subtle or atypical symptoms may indicate constipation in children with ASDs.
  • A deliberate approach to screening, identification, and treatment of underlying causes is recommended.
  • Diagnostic-therapeutic intervention and careful follow-up are crucial for effective management.
  • Limited evidence exists in the literature for evaluating and treating constipation in children with ASDs.

Conclusions:

  • A systematic approach can effectively identify and manage constipation and its underlying causes in children with ASDs.
  • The lack of existing research highlights a critical need for further investigation in this area.
Abstract

Related Concept Videos

Autism Spectrum Disorder01:19

Autism Spectrum Disorder

Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Modeling in Therapy01:26

Modeling in Therapy

Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in situations...
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Operant Conditioning Intervention01:24

Operant Conditioning Intervention

Operant conditioning serves as a foundational principle in therapeutic interventions aimed at modifying maladaptive behaviors. Central to this approach is the notion that behaviors, both adaptive and maladaptive, are learned through reinforcement. By analyzing the environmental factors that reinforce problematic behaviors, clinicians can design interventions to weaken these reinforcements and replace maladaptive behaviors with healthier alternatives.
In operant conditioning, behaviors that are...